C

Curia

End-to-end drug development and manufacturing

Site Quality Head

Full-Time
$186k - $230k/yr
Expert
Bachelor's
Camarillo, CA, USA
In Person
Biology & BiotechRegulatory & Quality (Life Sciences)
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree (BS or BA) in a scientific field is required; microbiology is preferred.
  • At least 15 years of progressively greater responsibility in Quality Operations in pharmaceutical sterile product manufacturing, biologics, or medical devices, including project, technical, and personnel management experience.
  • Effective communication skills to collaborate with others and proactively resolve obstacles.
  • Must pass a background check and drug screen.
  • May be required to pass occupational health screening.
  • May be required to obtain and maintain gowning certification.
  • May be required to obtain and maintain media qualification.
Responsibilities
  • Provide technical and quality oversight and support to the VP of Quality Operations in making quality decisions.
  • Ensure adequate manufacturing quality oversight across manufacturing operations and oversee all aspects of GMP compliance, from material dispensing through final product dispatch for all products.
  • Provide guidance and processes that comply with global cross-contamination control requirements.
  • Support plant management groups on new products and changes to products, processes, and services to achieve a consistent approach to Quality Assurance and Regulatory Affairs.
  • Direct site quality and compliance process improvements and goals using current regulations and demonstrated best practices.
  • Support effective and efficient continuous quality and cost improvement efforts.
  • Ensure Curia global Quality Systems requirements are implemented and maintained in each facility operation.
  • Drive accountability for decisions affecting product and process quality and determine when escalation is needed.
  • Provide leadership, subject-matter expertise, and direction to the Quality Organization.
  • Evaluate and recommend solutions and implementation strategies for product and process issues using analytical, technical, and leadership skills.
  • Develop, direct, and manage the Manufacturing Quality Assurance function.
  • Develop, direct, and manage the Quality Control function, including the microbiology and chemistry laboratories and environmental monitoring.
  • Develop, direct, and manage the Quality Systems and Compliance function.
  • Develop, direct, and manage the Quality Assurance function.
  • Manage resources to ensure stability testing is completed on time to meet customer requirements.
  • Hire and retain talent and support team members' career development.
  • Provide plant management with data and information to reduce potential regulatory action and assist with site productivity management; keep plant management informed of agency, customer, and internal audit compliance commitments.
  • Develop and maintain the site's Quality budget.
Desired Qualifications
  • Microbiology is the preferred scientific field for the required BS or BA degree.

About the company

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.